Keratized Mucosa in CG Implant Placement: CTG vs Flapless
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Connective tissue graft, Flapless.
- Who it may be relevant to
- Registry conditions: Variation of Keratinized Mucosa After Implant Surgery. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Italy
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Width of Keratinazed Mucosa in Immediately Loaded Posterior Implant Restorations Treated With Different Surgical Approaches: Randomized Clinical Study.
Overview
The present study will evaluate the difference in terms of keratinazed mucosa (KM) in computer guided implant placement with immediate loading, comparing a flapless approach to flap surgery with connective tissue graft.
Interventions
- Procedure Connective tissue graft
Implants will be placed with a flap and a connective tissue graft. - Procedure Flapless
Implants will be placed with a flapless approach
Primary outcome measures
- Widht of Keratinized mucosa [Time frame: 2-4-8-12-24 weeks - 1-2-3-4-5 years]
Secondary outcome measures (3)
- implant survival [Time frame: 1-2-3-4-5 years]
- marginal bone loss [Time frame: 1-2-3-4-5 years]
- Vas Scale [Time frame: 2 weeks]
Eligibility criteria
Inclusion criteria
- Age 18+
- Patients with partial edentulism in the posterior region (4-7) upper or lower for at least 3 months
- Patient whose tomographic examination shows adequate bone volumes for computer guided placement of a standard diameter implant (> 3.5 mm) without the need for bone regeneration procedures
- Patients who have accepted informed consent and participation in the study
- Patients who do not have exclusion criteria
Eclusion Criteria
- Patients who refuse to co-operate
- Systemic conditions of exclusion:
- Medical conditions requiring prolonged use of steroids
- Severe hemophilia
- In therapy with intravenous bisphosphonates
- History of white blood cell dysfunction or deficiency
- History of head and neck radiotherapy or chemotherapy
- History of kidney failure
- Pregnant or breastfeeding patient
- History of uncontrolled endocrine disorders
- Physical handicaps that hinder proper oral hygiene
- Use of experimental devices or drugs within 30 days prior to implant placement surgery
- Alcoholism or drug abuse
- Smokers of> 10 cigarettes per day or the equivalent cigar or> 10 tobacco-based chewings per day
- Conditions or circumstances that prevent the completion of participation in the study or interfere with the analysis of the study results
Local exclusion conditions:
- Local inflammation, including untreated periodontitis
- Patients with erosive lichen planus
- History of local radiation therapy
- Presence of bone lesions
- Unhealed extraction sites
- History of bone reconstruction and bone grafting techniques in the sites where the implants are to be inserted
- Bruxism
- Bleeding index> 30% and number of pockets> 5mm greater than 10
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Diagnostic
Study locations
Italy · 1 center
- Clinica Odontoiatrica Giorgio Vogel — Milan
Identifiers
NCT: NCT05073952 · KM001